Insight Molecular Diagnostics Inc.
IMDXNasdaqCIK 1642380HealthcareFiscal year ends Dec 31
Reports and events: 266 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-09-2116:05 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-26-043560 |
| 2026-08-1016:14 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001642380-26-000011 |
| 2026-08-1016:10 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-036863 |
| 2026-06-1716:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-26-029078 |
| 2026-05-1316:15 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001642380-26-000008 |
| 2026-05-1316:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-26-022721 |
| 2026-05-1316:05 ET | 8-K/A | 8.01 Other events | 0001493152-26-022708 |
| 2026-04-3016:14 ET | DEF 14A | Proxy statementPeriod 2026-04-30 | 0001493152-26-020502 |
| 2026-04-3016:07 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-020461 |
| 2026-04-2719:14 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000919574-26-002415 |
| 2026-03-2616:13 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001642380-26-000004 |
| 2026-03-2616:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-26-012915 |
| 2026-02-2616:06 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-26-008169 |
| 2026-02-1219:52 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000919574-26-000780 |
| 2026-02-1217:20 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-006473 |
| 2026-02-1108:05 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-006117 |
| 2025-11-1016:15 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-274266 |
| 2025-11-1016:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-25-021513 |
| 2025-10-0216:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-25-016685 |
| 2025-09-1916:05 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001493152-25-014240 |
| 2025-08-1116:11 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000950170-25-106552 |
| 2025-08-1116:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001641172-25-022974 |
| 2025-07-0217:01 ET | 8-K | 5.07 Shareholder vote results | 0001641172-25-017590 |
| 2025-06-1707:33 ET | 8-K | 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-015338 |
| 2025-05-1417:07 ET | DEF 14A | Proxy statementPeriod 2025-05-14 | 0001641172-25-010366 |
| 2025-05-1216:12 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000950170-25-069213 |
| 2025-05-1216:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001641172-25-009681 |
| 2025-04-1717:17 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001641172-25-005288 |
| 2025-03-2813:25 ET | S-1 | Registration statement | 0001641172-25-001331 |
| 2025-03-2416:16 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000950170-25-043852 |
| 2025-03-2416:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001641172-25-000283 |
| 2025-03-1016:05 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001493152-25-009684 |
| 2025-02-1020:46 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000919574-25-000923 |
| 2025-02-1009:17 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-005563 |
| 2025-01-0816:05 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-25-001389 |
| 2024-11-1216:08 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0000950170-24-125365 |
| 2024-11-1216:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-24-044741 |
| 2024-10-1516:22 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-24-041133 |
| 2024-10-0306:05 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-039269 |
| 2024-09-2516:09 ET | DEF 14A | Proxy statementPeriod 2024-09-25 | 0001493152-24-038106 |
| 2024-08-0906:37 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 9.01 Financial statements and exhibits | 0001493152-24-030865 |
| 2024-08-0816:27 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001493152-24-030793 |
| 2024-08-0816:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-24-030771 |
| 2024-07-1216:05 ET | 8-K | 3.01 Delisting notice | 0001493152-24-027086 |
| 2024-07-0516:01 ET | 8-K | 5.07 Shareholder vote results; 8.01 Other events | 0001493152-24-026335 |
| 2024-06-1716:10 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-24-024108 |
| 2024-05-3116:05 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001493152-24-022193 |
| 2024-05-2316:05 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001493152-24-021144 |
| 2024-05-1516:21 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-24-019889 |
| 2024-05-1516:06 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001493152-24-019842 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:14 ET. Listed shows no prices and gives no investment advice.